Investigations of Microbial Fitness, Virulence, and Drug Resistance Infectious and opportunistic pathogens are a major cause of host morbidity and mortality. In this session we explore host immunity and the mechanisms by which microbes adapt to the host environment or exposure to antimicrobial agents. Better understanding host-microbe interactions and how microbes effectively respond to stress […]

Continue reading "Investigations of microbial fitness, virulence, and drug resistance" →

Cancer: Emerging Hallmarks and Enabling Characteristics The hallmarks of cancer – a phrase originally coined by Doug Hanahan and Bob Weinberg – comprise six biological capabilities acquired during cancer development: sustained proliferative signaling, the evasion of growth suppression, resistance to cell death, replicative immortality, angiogenesis, and invasion and metastasis. Over the past decade, two new […]

Continue reading "Cancer: Emerging Hallmarks and Enabling Characteristics" →

There is no Box: Equity, Diversity, and Inclusion in Medical Entrepreneurship EDI is finally getting attention from all corners of our industry. Entrepreneurs must understand the advantages of proactive engagement, and the consequences of lagging. This session will provide valuable perspectives on the topic from entrepreneurs, Faculty, universities, investors, government, and industry, and will be […]

Continue reading "There is no Box: Equity, Diversity, and Inclusion in Medical Entrepreneurship" →

From Neurocircuitry to Neuromodulation This translational session covers brain “wiring” and dynamics in animals and humans, focusing on myelin, pain, social interactions, and neuromodulation’s effects on human fear.  Specific topics: myelin plasticity/repair (Robert Hill); brain-behavior responses to painful stimuli (Amanda Crocker); human social interactions (Oriel FeldmanHall); and transcranial electrical stimulation’s effects on fear (Mascha van’t […]

Continue reading "From Neurocircuitry to Neuromodulation" →